850 related articles for article (PubMed ID: 17936059)
1. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
2. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
3. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
4. Improved lead-finding for kinase targets using high-throughput docking.
McInnes C
Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
[TBL] [Abstract][Full Text] [Related]
5. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
6. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
Rollinger JM; Haupt S; Stuppner H; Langer T
J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening - what does it give us?
Köppen H
Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
[TBL] [Abstract][Full Text] [Related]
8. Streamlining lead discovery by aligning in silico and high-throughput screening.
Davies JW; Glick M; Jenkins JL
Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
[TBL] [Abstract][Full Text] [Related]
9. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening in lead discovery and optimization.
Jain AN
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
[TBL] [Abstract][Full Text] [Related]
11. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
12. The discovery of Kv1.5 blockers as a case study for the application of virtual screening approaches.
Pirard B; Brendel J; Peukert S
J Chem Inf Model; 2005; 45(2):477-85. PubMed ID: 15807513
[TBL] [Abstract][Full Text] [Related]
13. Docking and scoring in virtual screening for drug discovery: methods and applications.
Kitchen DB; Decornez H; Furr JR; Bajorath J
Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
[TBL] [Abstract][Full Text] [Related]
14. The role of computational methods in the identification of bioactive compounds.
Glick M; Jacoby E
Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
[TBL] [Abstract][Full Text] [Related]
15. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
16. Using computational techniques in fragment-based drug discovery.
Desjarlais RL
Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
[TBL] [Abstract][Full Text] [Related]
17. A knowledge-based weighting approach to ligand-based virtual screening.
Stiefl N; Zaliani A
J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
[TBL] [Abstract][Full Text] [Related]
18. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer T; Krovat EM
Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
[TBL] [Abstract][Full Text] [Related]
19. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
20. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
Schlosser J; Rarey M
J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
